Branded

Sandoz is acquiring GSK’s cephalosporin antibiotics business, including three established brands, Zinnat, Zinacef and Fortum.

Libtayo is now approved for both advanced cutaneous squamous cell and basal cell carcinomas.

Upsher-Smith has expanded its Access Pathways Program to offer commercially insured patients a $0 co-pay and free home delivery for acute and preventive migraine treatment options.

ViiV Healthcare’s Cabenuva is the first Food and Drug Administration-approved injectable that is a complete regimen for HIV-infected adults administered once a month.

Merck's Verquvo offers a new treatment option for appropriate patients with symptomatic chronic heart failure.

GSK's Benlysta is now approved for patients with active lupus nephritis.

Agile Therapeutics’ once-weekly Twirla is the first and only contraceptive patch that combines levonorgestrel and ethinyl estradiol.

Genentech’s Xofluza now is indicated to include post-exposure prevention of influenza for patients 12 years old and older after contact with a person with the flu.